Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Prepaid Assets: 2010-2025

Historic Prepaid Assets for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Sep 2025 value amounting to $13.5 million.

  • Arrowhead Pharmaceuticals' Prepaid Assets rose 41.72% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 41.72%. This contributed to the annual value of $13.5 million for FY2025, which is 41.72% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Prepaid Assets stood at $13.5 million for FY2025, which was up 41.72% from $9.5 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Prepaid Assets ranged from a high of $20.2 million in FY2022 and a low of $4.4 million during FY2021.
  • Moreover, its 3-year median value for Prepaid Assets was $9.5 million (2024), whereas its average is $10.6 million.
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Prepaid Assets surged by 363.18% in 2022, and later slumped by 56.38% in 2023.
  • Yearly analysis of 5 years shows Arrowhead Pharmaceuticals' Prepaid Assets stood at $4.4 million in 2021, then soared by 363.18% to $20.2 million in 2022, then slumped by 56.38% to $8.8 million in 2023, then rose by 8.22% to $9.5 million in 2024, then skyrocketed by 41.72% to $13.5 million in 2025.